BackClarus Therapeutics Holdings Overview

Clarus Therapeutics Holdings Other Liabilities

Clarus Therapeutics Holdings's other liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Clarus Therapeutics Holdings Other Liabilities History

Loading

Clarus Therapeutics Holdings vs. peers: Other Liabilities Comparison

Loading

Clarus Therapeutics Holdings Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Clarus Therapeutics Holdings (CRXT) FAQ

Clarus Therapeutics Holdings (CRXT) currently reports a other liabilities of $0 as of June 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Clarus Therapeutics Holdings's other liabilities history and peer comparisons.

Clarus Therapeutics Holdings's other liabilities changed from $0 to $0 (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clarus Therapeutics Holdings reported $0 in other liabilities as of June 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clarus Therapeutics Holdings, and consider following CRXT for alerts when major investors trade the stock.